Sign up for our beta test at https://medengine.co
Find out more through our newsletter - https://bit.ly/2w4Ltt2
Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 15
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 19, 2025 | Parkinson's disease Drug Market | Forecasted to Cross Valuation of $10.4 Billion by 2031 | The global Parkinson's disease drugs market size is projected to reach $10.4 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031. PORTLAND, OR, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- Parkinson's disease (PD) drug refers... |
| May 10, 2023 | Parkinson's disease Drug Market | Forecasted to Cross Valuation of $10.4 Billion by 2031 | The global Parkinson's disease drugs market is projected to reach $10.4 billion by 2031, growing at a CAGR of 6.2% from 2022 to 2031. PORTLAND, OREGON, UNITED STATES, May 11, 2023 /EINPresswire.com/ -- Parkinson's disease (PD) drug refers t... |
| Feb 1, 2021 | EIT Health invests €3M in innovations for endometrial cancer and Parkinson's disease | Credit: Wild Card programme winners |
| Sep 11, 2018 | Parkinson SuperWalk raises more than $30,000 in Charlottetown | Dan Steele, president of the P.E.I. Chapter of Parkinson Canada, led the way for the annual Parkinson SuperWalk in Charlottetown. This year’s event raised $30,880. “It’s a way to get to meet people who have family members that have Parkinso... |
| Apr 10, 2018 | FDA-cleared wearable for Parkinson’s disease patients gets $6M+ funding boost | The wearable, styled as a smartwatch, generates a score for bradykinesia — a slowness of movement associated with Parkinson’s disease, dyskinesia — involuntary muscle movements, and tremor. The smartwatch is worn for seven days before it is... |
| Mar 8, 2018 | Parkinson’s startup Prevail raises $75M for gene therapy programs | OrbiMed-backed Prevail Therapeutics has launched a $75 million first-round financing that will help fund development of its gene therapy for Parkinson’s disease (PD) and other programs. Prevail was set up last year by OrbiMed's co-head of p... |
| Aug 8, 2017 | Parkinson's Foundation Announces $1.2 Million Investment | The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's. "We are proud to continue ... |
| Apr 16, 2014 | Parkinson's sensor company will use $1.5M NIH grant for consumer product | Great Lakes NeuroTechnologies, a company using tablets and wearable sensors for Parkinson's diagnosis and therapy, will use a recent $1.5 million NIH grant to start a move toward direct-to-consumer marketability. This is the latest in a lon... |
| Apr 20, 2012 | Parkinson’s disease monitoring company secures $4.5M in new funding | Great Lakes’ Kinesia movement disorder assessment technology uses a ring-like sensor worn on a patient’s finger to measure motor symptoms and wirelessly transmit data on the severity of a patient’s tremors. Understanding the type and severi... |
Reviews 0
FAQ about MedEngine
What has the press written about MedEngine?
Parsers VC has collected 15 articles mentioning MedEngine, among them “Parkinson's disease Drug Market | Forecasted to Cross Valuation of $10.4 Billion by 2031” (Jun 19, 2025) and “Parkinson's disease Drug Market | Forecasted to Cross Valuation of $10.4 Billion by 2031” (May 10, 2023).
Is MedEngine still active?
Yes, MedEngine is active; its latest activity on Parsers VC dates from Oct 7, 2026.